Glenmark Pharma has sold its gynaecology business to private equity firm True North backed Integrace Pharma in an attempt to cut down debt of the company. The sale of the gynac business comes two years after it sold its orthopedic business to the same company. Integrace will pay Rs 115 crore for four products of the portfolio that includes products like Dubagest, Mumfer and Fenza.

— The Economic Times

Cyril Amarchand Mangaldas advised Glenmark Pharmaceuticals Limited led by a team of partner Manisha Kumar, with support from senior associate Aviral Chauhan.

2020-01-21

Deal value: Confidential

This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.